Juan Ramón Navarro

Médico Hematólogo Hosp. Rebagliati - LIMA Hematology and HSCT in Perú

[Juan Ramón Navarro @juanrnavarroc]

Myeloproliferative Neoplasms | New England Journal of Medicine https://t.co/5Gf9EujoUk

[Juan Ramón Navarro @juanrnavarroc]

Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy | New England Journal of Medicine https://t.co/KI6Cv5VruM

[Juan Ramón Navarro @juanrnavarroc]

Interesante alternativa
All-Trans Retinoic Acid for Immune Thrombocytopenia — Sustained Response? | NEJM Evidence https://t.co/QXltk9kD7F

[Juan Ramón Navarro @juanrnavarroc]

@saludconlupa Este truco legal limita la cobertura al paciente, no siempre se usara lo que realmente necesita.
Es usual en Peru y marca la diferencia entre los seguros especialmente si es necesario procedimientos o medicamentos de alto costo.

[Juan Ramón Navarro @juanrnavarroc]

@saludconlupa @ICIJorg El estado debe implementar YAAA lo que existe en la norma ACUERDOS DE COMPRA
CONFIDENCIALES EN MEDICAMENTOS DE ALTO COSTO tal como aplica UK y PAGO POR RESULTADOS.
No debe prohibir el uso si existen bases evidencia solida para su uso, pero el estado debe protegerse con candados.

[Talha Badar @TalhaBadarMD]

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring #TP53 mutations https://t.co/fPsUxBuKFy @MayoClinic @MayoCancerCare #leusm

[Juan Ramón Navarro @juanrnavarroc]

Monoclonal Gammopathy of Undetermined Significance | New England Journal of Medicine https://t.co/6szgY5RtkK

[Juan Ramón Navarro @juanrnavarroc]

@giorgio_orofino @TheEBMT @TheIACH Lecciones aprendidas

[The Innovation | Medicine @Innov_Medicine]

Antibiotic sensitivities h/t @Sthanu5
#MedEd #MedTwitter #FOAMed

[Juan Ramón Navarro @juanrnavarroc]

Impact of Treatments Before Allogeneic HSCT in Patients With Higher-Risk Myelodysplastic Syndrome https://t.co/W7AhGp4Xve vía @practiceupdate

[Juan Ramón Navarro @juanrnavarroc]

@AML_Hub Buenos resultados en LMA con IDH 1/2 mutado y luego sigue como mantener esta respuesta. Seguir hasta la progresión…..

[Juan Ramón Navarro @juanrnavarroc]

Long-Term Outcomes of Patients With CML Who Commenced Treatment With Imatinib https://t.co/jccm40zYme a través de @practiceupdate
EUTOS long-term survival score may help clinicians adapt treatment.

[Juan Ramón Navarro @juanrnavarroc]

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia | NEJM https://t.co/zEqzE2cHuK

[Juan Ramón Navarro @juanrnavarroc]

Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation https://t.co/z6U0zkZ9eY

[Juan Ramón Navarro @juanrnavarroc]

Para tenerlo presente en nuestro medio / con recursos limitadosCost-Effectiveness of Second-Line Therapies in Adults With Chronic Immune Thrombocytopenia https://t.co/s4BDTrgM7g vía @practiceupdate

[Juan Ramón Navarro @juanrnavarroc]

Prevalence and Impact of a Platelet Count Limit of 1.5 Million at Essential Thrombocythemia Diagnosis | comment: Ayalew Tefferi MD https://t.co/s9X0Y9UgC0 vía @practiceupdate

[Juan Ramón Navarro @juanrnavarroc]

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia https://t.co/uLd7E53Wli

[Eric Feigl-Ding @DrEricDing]

Claim: “67% of #COVID hospitalized are vaccinated? Vaccines not working?”

📍No—due to “base rate fallacy”. To illustrate—suppose 50% of unvaccinated are hospitalized, while 10% of vaxxed are, but many more vaccinated. You can get the 67% above.

➡️Don’t be misled!

By @MarcRummy

[Juan Ramón Navarro @juanrnavarroc]

Myelodysplasia and Bone Marrow Manifestations of Somatic UBA1 Mutated Autoinflammatory Disease | Blood | American Society of Hematology
NUEVA CAUSA DE CITOPENIA CLONAL CON CARACTERISTICAS MORFOLOGICAS EN MEDULA x MUTACION UBA1 https://t.co/GZxjl7LYVt

[Juan Ramón Navarro @juanrnavarroc]

Interesantes resultados con la adición de EPAG al tto inmunosupresor. Habrá que observar la profundidad y tiempo de respuesta https://t.co/68rKW3l9AW